logo
Introduction
Brofaromine for Social Phobia
Moclobemide in Social Phobia
Clonazepam in the Treatment of Panic Disorder With or Without Agoraphobia
Clinical Improvement With Fluoxetine Therapy and Noradrenergic Function in Patients With Panic Disorder
Effects of Cholecystokinin Tetrapeptide on Respiratory Function in Healthy Volunteers
Efficacy of Divalproex Sodium in Patients With Panic Disorder and Mood Instability Who Have Not Responded to Conventional Therapy
Patient Treatment Insistence and Medication Craving in Long-term Low-Dosage Benzodiazepine Prescriptions
Comparison of Paroxetine and Nortriptyline in Depressed Patients With Ischemic Heart Disease
Rapid Conversion From One Monoamine Oxidase Inhibitor to Another
Efficacy and Tolerability of Once-daily Venlafaxine Extended Release (XR) in Outpatients With Major Depression
A Double-Blind, Placebo-controlled Trial of Nefazodone in the Treatment of Patients Hospitalized for Major Depression
Methodological Problems in the Estimation of the Onset of the Antidepressant Effect
Effects of Trazodone and Fluoxetine in the Treatment of Major Depression
Dose Escalation vs. Continued Doses of Paroxetine and Maprotiline
Pharmacological Choices After One Antidepressant Fails
Should Anxiety and Insomnia Influence Antidepressant Selection
Fluoxetine in Breast-Milk and Developmental Outcome of Breast-fed Infants
Serum Sertraline and N-Desmethylsertraline Levels in Breast-feeding Mother-Infant Pairs
Serum Levels of Valproate and Carbamazepine in Breast-feeding Mother-Infant Pairs
Pregnancy Outcome Following Maternal Use of the New Selective Serotonin Reuptake Inhibitors
Safety of Abrupt Discontinuation of Fluoxetine
Meta-analysis of Trials Comparing Antidepressants With Active Placebos
ECT Treatment and Cerebral Perfusion in Catatonia
Hypothesis Testing
A Double-blind, Controlled Comparison of the Novel Antipsychotic Olanzapine Versus Haloperidol or Placebo on Anxious and Depressive Symptoms Accompanying Schizophrenia
Clozapine Treatment in Australia
Pharmacokinetic Interactions of Clozapine With Selective Serotonin Reuptake Inhibitors
Treatment of Tardive Dyskinesia
Cocaine as a Risk Factor for Neuroleptic-induced Acute Dystonia
Enhanced Sensitivity to Benzodiazepines in Active Cocaine-abusing Subjects
Imipramine Treatment of Opiate-dependent Patients With Depressive Disorders
Potential Role for Estrogen Replacement in the Treatment of Alzheimer's Dementia
Valproic Acid Treatment of Agitation in Dementia
Benzodiazepines May Have Protective Effects Against Alzheimer Disease
Use of Selective Serotonin-Reuptake Inhibitors or Tricyclic Antidepressants and Risk of Hip Fractures in Elderly People
Clinical Efficacy of Methylphenidate in Conduct Disorder With and Without Attention Deficit Hyperactivity Disorder
Benzodiazepine-receptor Ligands in Humans